News

Weill Cornell Medicine faculty members were honored with awards for their exemplary achievements in medical...

Weill Cornell Graduate School of Medical Sciences celebrated students in the Class of 2026 for their academic achievements during its convocation ceremony on May 13.

Medical and physician assistant students from the Class of 2026 were honored during convocation and certificate ceremonies May 13 for their dedication to scholarship, excellence in research, devotion to teaching or service and exceptional professional qualities.

Over 200 scientists, startup founders and partners in government and industry gathered at Uris Auditorium on April 23 for the 2026 BioInnovate Conference. 

Weill Cornell Medicine-Qatar celebrated its largest ever graduating class, which also includes a record 22 Qatari nationals, during the institution’s commencement ceremony May 5.

Weill Cornell Medicine investigators studying a bacterial protein have identified a new mechanism of sensing cold temperatures. 

A pilot program aimed at reducing Medicaid drug spending has limitations, according to a multi-institutional research team including faculty from Weill Cornell Medicine.

Weill Cornell Medicine investigators have “reverse engineered” ketamine’s antidepressant effects to identify potential new strategies for treating depression.

While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in arrests still exist, according to a new study led by Weill Cornell Medicine. 

Awards, honors and achievements for the month of April.

Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine. 

The 45th annual Vincent du Vigneaud Memorial Research Symposium, a student-organized event that has become central to the Weill Cornell Graduate School of Medical Sciences experience, had a record number of 153 abstracts submitted this year, including posters and eight oral presentations.

Nerve fibers within melanomas can slow the growth of these tumors, according to a study led by Weill Cornell Medicine investigators. 

Even as the national conversation around diversity, equity and inclusion is muted, Weill Cornell Medicine continues its work to make sure everyone has a seat at the table. That was the message relayed on April 23 by Dr. Linnie Golightly, provost and senior associate dean of academic affairs at CUNY School of Medicine. 

Dr. Boudker was among four Cornell faculty members to be elected into the academy this year.

The project will be one of the first major efforts of the Medicaid Policy Impact Initiative, a new cross-campus Cornell program aimed at supporting evidence-based policymaking in Medicaid.

Dr. William Schpero has seen firsthand how public policy drives patient outcomes at the population level, cementing a core idea that continues to guide his work as a health economist: that policy can be a powerful force for improving health equity — or, if poorly designed, a barrier to it. 

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.” 

Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate chronic inflammation in the intestine, potentially opening new avenues for therapies against inflammatory bowel disease (IBD), food allergy and other autoimmune conditions.

On April 20, Weill Cornell Medicine awarded the Pioneers in Diversity Awards, recognizing commitment to diversity and inclusion through mentorship, service and advocacy.